This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-11-07 SGB Conference Call"

From HL7Wiki
Jump to navigation Jump to search
Line 37: Line 37:
 
===============================================================================--->
 
===============================================================================--->
 
|-
 
|-
| || Calvin Beebe
+
|Regrets || Calvin Beebe
 
|-
 
|-
 
| ||Lorraine Constable
 
| ||Lorraine Constable
Line 49: Line 49:
 
| || Ewout Kramer
 
| || Ewout Kramer
 
|-
 
|-
| || Austin Kreisler
+
|Regrets || Austin Kreisler
 
|-
 
|-
 
| || Wayne Kubick
 
| || Wayne Kubick
Line 147: Line 147:
  
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
*[[2018-mm-dd SGB Conference Call]]
+
*[[2018-11-14 SGB Conference Call]]
  
 
|}
 
|}
  
 
© 2018 Health Level Seven® International.  All rights reserved
 
© 2018 Health Level Seven® International.  All rights reserved

Revision as of 14:54, 7 November 2018

back to Standards Governance Board main page

HL7 SGB Minutes

Location:
https://global.gotomeeting.com/join/538465637

Date: 2018-MM-DD
Time: 10:00 AM Eastern
Facilitator Paul/Lorraine Note taker(s) Anne
Attendee Name


Regrets Calvin Beebe
Lorraine Constable
Russ Hamm
Tony Julian
Paul Knapp
Ewout Kramer
Regrets Austin Kreisler
Wayne Kubick
Thom Kuhn
Ken McCaslin
Rik Smithies
Sandy Stuart
Quorum: Chair + 4

Agenda

  • Agenda review
  • Approve Minutes of 2018-10-31_SGB_Conference_Call
  • Action Items
    • Paul to contact PA re: approval items balloting at STU in FHIR R3
      • Will then verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
    • Paul to ask PH for clarification on the status of items taken out of tracker and then reconciled on spreadsheet/ask for a plan for addressing the issue
    • Paul to draft precept on artifact governance
    • Wayne to reach out to Argonaut project leads re: Argonaut diagnostic report development (from 2018-10-05 WGM meeting)
    • Anne to work with Josh to set up SGB page to communicate decisions/precepts by January
    • Austin to discuss separation of concerns issue with Lloyd (from 2018-10-24 call)
    • Group to review Project Life Cycle for Product Development (PLCPD) document and add to agenda for 2018-11-14 call (from 2018-10-31 Call)
    • Wayne to compare CDAMG resppointments against the preponderance of influence reporting system (from 2018-10-31 Call)
  • Discussion Topics
    • CDAMG reappointments
    • Issues and risks around balloted vs. non-balloted feedback in FHIR from different perspectives
    • Continued discussion: Currency of Value Set Content
    • SGB Communication Plan
    • Updates that we do to newer versions of FHIR that are also applicable to older versions
    • Precepts We Need to Develop
  • Parking Lot
    • Mapping coordination
    • Add link to Confluence page from ARB page
    • Review of product management life cycle spec to see if it talks about project and ballot scope
    • Review of MG responses to SGB query on substantive change
    • Need to make sure that SGB is accurately reflected in the GOM, and figure out what precepts should appear in the GOM
    • Review Mission and Charter
    • Drafting Shared Product Management Responsibilities
    • Technical Alignments Between Product Families
    • How groups are to interact with publishing, EST, Vocabulary, etc.
    • Precept on bringing in large projects
    • Vocabulary - review HTA material for precepts
    • Precept for adding new tools (include that WGs with a specific mandate must be involved, such as EST, Publishing, Vocabulary, etc.) - was this covered by the tooling precept we created in New Orleans?
    • BAM guidance on process for product adoption
    • Create PRECEPTS that require that it be articulated in the standards how the value sets specified within the standards respond to changes in regulation, licensing, time, etc.- to do in April/before Cologne
    • FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
    • Ownership of content
    • What precepts do we need to address PSS/profile approval processes of balloting and publishing potentially thousands of CIMI model?

Minutes

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2018 Health Level Seven® International. All rights reserved